Analyzing the Clinical Efficacy of Thrombolytic Therapy in Elderly Pa-tients with Acute Myocardial Infarction
Objective To explore the effectiveness of thrombolytic therapy for elderly patients with acute myocardial infarction(AMI).Methods A total of 66 elderly AMI patients admitted to the People's Hospital of Hulunbuir City from May 2022 to May 2023 were objectively selected as the study objects.They were divided into a control group(n=32)and an observation group(n=34)by difference treatment.The control group received conservative treatment,while the observation group received intravenous thrombolysis with prourokinase.The 2 h relief rate of chest pain symptoms,coronary artery recanalization rate,and incidence of vascular adverse events were compared between the two groups.Results The 2 h relief rate of chest pain symptoms(85.29%)and coronary artery recanalization rate(82.35%)in the observation group were higher than those in the control group,and the differences were statistically significant(χ2=5.583,5.318,both P<0.05).After treatment,the observation group had better left ventricular end systolic diameter,end diastolic diameter,and ejection fraction than the control group,the differences were statistically significant(all P<0.05).The incidence of adverse cardiovascular events in the observation group(2.94%)was lower than that in the con-trol group(21.88%),and the difference was statistically significant(χ2=3.913,P<0.05).Conclusion The early clinical application of prourokinase thrombolysis has a significant effect on the treatment of elderly AMI.
Acute myocardial infarction in the elderlyThrombolytic therapyClinical efficacyinfluence factor
NETL
NSTL
万方数据
